French drugmaker Pierre Fabre Médicaments will pay $75m for an exclusive licence to to commercialise Urovant...
Up To Date
Latest News
German mRNA vaccine developer CureVac, whose COVID-19 vaccine was not effective, on Monday sued...
Shares of French drugmaker Ipsen fell by 4.4% at Euronext Paris after the company announced to take over US...
At the end of the TWB Start-up day, which was attended by more than 200 biotech professionals, two industrial...
BioNTech SE has announced it is going to ship the first containers for mRNA malaria vaccine production from...
In an effort to become a major player in Europe’s growing pharmaceutical-grade cannabis market, Danish Canify...